Meeting
2021 ASCO Annual Meeting
Survival and organ preservation according to clinical response after total neoadjuvant therapy in locally advanced rectal cancer patients: A secondary analysis from the organ preservation in rectal adenocarcinoma (OPRA) trial.
Authors
Hannah Thompson
Colorectal Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY
Hannah Thompson , Jin Ki Kim , Jonathan B. Yuval , Floris Verheij , Sujata Patil , Marc J Gollub , Abraham Jing-Ching Wu , Meghan Lee , Aram F Hezel , Jorge Marcet , Peter Cataldo , Blase N. Polite , Daniel Herzig , David Liska , Samuel Oommen , Charles Friel , Charles A. Ternent , Andrew L. Coveler , Steven R. Hunt , Julio Garcia-Aguilar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Clinical Trial Registration Number
NCT02008656
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3509)
DOI
10.1200/JCO.2021.39.15_suppl.3509
Abstract #
3509
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
No operation after short course radiotherapy followed by consolidation chemotherapy in locally advanced rectal cancer: The prospective, single arm NOAHS-ARC trial.
First Author: Felipe Fernando Quezada
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Ensemble study: A multicenter, randomized, phase III trial to test the superiority of consolidation irinotecan, capecitabine and oxaliplatin vs capecitabine and oxaliplatin following short course radiotherapy as total neoadjuvant therapy in patients with locally advanced rectal cancer.
First Author: Jun Watanabe
Poster
2022 ASCO Annual Meeting
Clinical and radiological predictors of organ preservation in patients with rectal cancer treated with total neoadjuvant therapy.
First Author: Jonathan B Yuval
Poster
2020 Gastrointestinal Cancers Symposium
An assessment of dose intensity of the TNT approach on outcomes in locally advanced rectal cancer.
First Author: Ashley Elizabeth Glode